Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Readers Comments

Back to Item »

Agennix Contracts Lonza for Commercial Manufacturing of Its Oral NSCLC Immunotherapy

Talactoferrin is in Phase III, and DSM is already on board as a producer.

0 Readers' Comments
  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll